Artigo Revisado por pares

Influence of early discovery safety on eliminating off-target insulin receptor activity and selection of the candidate drug AZD9291

2014; Elsevier BV; Volume: 229; Linguagem: Inglês

10.1016/j.toxlet.2014.06.221

ISSN

1879-3169

Autores

Mark J. Anderton, Richard J. Ward, Anne Galer, Darren A.E. Cross, Louise Marks, Ray Finlay,

Tópico(s)

Pharmaceutical studies and practices

Referência(s)
Altmetric
PlumX